APOD and Alzheimer disease: More recent studies have sown that loss of apoD in the APP/PS1 amyloidogenic Alzheimer’s disease (AD) mouse model significantly worsens AD pathology, whereas neuronal expression of human apoD in the same AD mouse model reduces AD pathology [19].